Paul Martin
- Oncology top 5%
- Surgery top 5%
- Molecular Biology
- Pharmacology top 1%
- Economics and Econometrics top 5%
- Co-authors
- Dennis W. SchneckAaron DaneMike J. WarwickPat MitchellJennifer S. McKayPaul D. SmithRichard O. JenkinsBarry R. Davies
- Topics
- Lipoproteins and Cardiovascular Health (16 papers)PI3K/AKT/mTOR signaling in cancer (9 papers)Drug Transport and Resistance Mechanisms (9 papers)
- Cited by
- PharmacologyOncologySurgery
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Paul Martin
49 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 103
- Oncology 799
- Surgery 705
- Molecular Biology 570
- Pharmacology 383
- Economics and Econometrics 268
Countries citing papers authored by Paul Martin
This map shows the geographic impact of Paul Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Martin more than expected).
Fields of papers citing papers by Paul Martin
This network shows the impact of papers produced by Paul Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Martin. The network helps show where Paul Martin may publish in the future.
Co-authorship network of co-authors of Paul Martin
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Martin. A scholar is included among the top collaborators of Paul Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Martin. Paul Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 49 | |
| 2 | 29 | |
| 3 | 24 | |
| 4 | 23 | |
| 5 | 34 | |
| 6 | 15 | |
| 7 | 0 | |
| 8 | 52 | |
| 9 | 26 | |
| 10 | 322 | |
| 11 | 51 | |
| 12 | Pharmacokinetics, tissue distribution and anti-tumor activity of the Src/Abl kinase inhibitor AZD0530 in a rat xenograft model | 2 |
| 13 | 23 | |
| 14 | 52 | |
| 15 | 77 | |
| 16 | 77 | |
| 17 | 233 | |
| 18 | 92 | |
| 19 | 42 | |
| 20 | 56 |
About Paul Martin
Paul Martin is a scholar working on Genetics, Hematology and Pharmacology, having authored 50 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (16 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Drug Transport and Resistance Mechanisms (9 papers). The work is most often cited by research in Pharmacology (383 citations), Oncology (799 citations) and Surgery (705 citations). Paul Martin has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Dennis W. Schneck, Aaron Dane, Mike J. Warwick, Pat Mitchell, Jennifer S. McKay, Paul D. Smith, Richard O. Jenkins, Barry R. Davies, Armelle Logié and Mark Cockerill. Their work appears in journals such as Blood, Journal of the American College of Cardiology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.